Latest filing published 29 Sept 2026 for ADARx Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
LAV Biosciences Fund V, L.P.: trading record in brief
LAV Biosciences Fund V, L.P. is a declared insider at 2 companies; the most frequent names are Terns Pharmaceuticals, Inc. and ADARx Pharmaceuticals, Inc. Between 9 February 2021 and 28 September 2026, the trades on record add up to 13 filings.
No open-market purchase appears, only 3 sales worth €8.0M.
The latest filing, published on 29 September 2026, reports a transaction in ADARx Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to LAV Biosciences Fund V, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,908,775 sharesCommon StockSEC:0001231919-26-001406:0
- 1,667,469 sharesCommon StockSEC:0001231919-26-001406:1
- 513,067 sharesCommon StockSEC:0001231919-26-001406:2
- 153,868 sharesCommon StockSEC:0001231919-26-001406:3
- 307,738 sharesCommon StockSEC:0001231919-26-001406:4
- 307,738 sharesCommon StockSEC:0001231919-26-001406:5
- 1,000,000 shares@ US$5.50100.0% of flowCommon StockSEC:0001209191-22-058874:0
7 of 7 declarations
